Lawrence Blatt

Lawrence Blatt, MBA., Ph.D., co-founded Aligos Therapeutics, Inc., and currently serves as the Chief Executive Officer and a member of the Board of Directors since March 2018. Dr. Blatt has more than 29 years of drug research and development experience with a specific focus on biology of the immune system, infectious diseases, antiviral therapies, and relevant therapeutic interventions. Prior to Aligos, he was the Global Head of Infectious Diseases and Vaccines at Johnson & Johnson.